AnaptysBio, Inc. Common Stock When Issued (ANABV) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

AnaptysBio, Inc. Common Stock When Issued (ANABV) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.26B, listed on NASDAQ, carrying a beta of 0.41 to the broader market. AnaptysBio, Inc. Led by Daniel R. Faga, public since 2026-04-06.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for ANABV as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →